In the present study, the prevalence of simultaneous GGT and ALT abnormalities in Chinese patients with NAFLD was 46.4%, which was similar to another large-scale cross-sectional study conducted in China, in which over 50% of patients with NAFLD presented abnormal serum liver enzyme levels [31]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.